학술논문
전자자료 공정이용 안내
우리 대학 도서관에서 구독·제공하는 모든 전자자료(데이터베이스, 전자저널, 전자책 등)는 국내외 저작권법과 출판사와의 라이선스 계약에 따라 엄격하게 보호를 받고 있습니다.
전자자료의 비정상적 이용은 출판사로부터의 경고, 서비스 차단, 손해배상 청구 등 학교 전체에 심각한 불이익을 초래할 수 있으므로, 아래의 공정이용 지침을 반드시 준수해 주시기 바랍니다.
공정이용 지침
- 전자자료는 개인의 학습·교육·연구 목적의 비영리적 사용에 한하여 이용할 수 있습니다.
- 합리적인 수준의 다운로드 및 출력만 허용됩니다. (일반적으로 동일 PC에서 동일 출판사의 논문을 1일 30건 이하 다운로드할 것을 권장하며, 출판사별 기준에 따라 다를 수 있습니다.)
- 출판사에서 제공한 논문의 URL을 수업 관련 웹사이트에 게재할 수 있으나, 출판사 원문 파일 자체를 복제·배포해서는 안 됩니다.
- 본인의 ID/PW를 타인에게 제공하지 말고, 도용되지 않도록 철저히 관리해 주시기 바랍니다.
불공정 이용 사례
- 전자적·기계적 수단(다운로딩 프로그램, 웹 크롤러, 로봇, 매크로, RPA 등)을 이용한 대량 다운로드
- 동일 컴퓨터 또는 동일 IP에서 단시간 내 다수의 원문을 집중적으로 다운로드하거나, 전권(whole issue) 다운로드
- 저장·출력한 자료를 타인에게 배포하거나 개인 블로그·웹하드 등에 업로드
- 상업적·영리적 목적으로 자료를 전송·복제·활용
- ID/PW를 타인에게 양도하거나 타인 계정을 도용하여 이용
- EndNote, Mendeley 등 서지관리 프로그램의 Find Full Text 기능을 이용한 대량 다운로드
- 출판사 콘텐츠를 생성형 AI 시스템에서 활용하는 행위(업로드, 개발, 학습, 프로그래밍, 개선 또는 강화 등)
위반 시 제재
- 출판사에 의한 해당 IP 또는 기관 전체 접속 차단
- 출판사 배상 요구 시 위반자 개인이 배상 책임 부담
'학술논문'
에서 검색결과 438건 | 목록
1~20
Academic Journal
EUROPEAN JOURNAL OF IMMUNOLOGY. 51(3):682-693
Academic Journal
Sawicka, Katherine M. ; Feldman, Brian M. ; Banwell, Brenda ; Beyene, Joseph ; Cragg, Jacquelyn J. ; Bar-Or, Amit ; Finlayson, Marcia ; Guenette, Melanie ; Lynd, Larry ; Raufdeen, Fasna ; Toulany, Alene ; Traboulsee, Anthony ; Yeh, E. Ann ; Oh, Jiwon
In Multiple Sclerosis and Related Disorders December 2025 104
Academic Journal
Dagnew, Baye ; Laslett, Laura L ; Honan, Cynthia A ; Taylor, Bruce V ; Saul, Alice ; van der Mei, Ingrid
In Multiple Sclerosis and Related Disorders November 2025 103
Academic Journal
Greenhough, Luke A. ; Clarke, Gabriella ; Phillipou, Alexander N. ; Mazani, Faith ; Karamshi, Bhumika ; Rowe, Sam ; Rowland, Paul ; Messenger, Cassie ; Haslam, Carl P. ; Bingham, Ryan P. ; Craggs, Peter D.
In SLAS Discovery June 2021 26(5):663-675
Academic Journal
Andromalos, Laura; Crowley, Nina; Brown, Jennifer; Craggs-Dino, Lillian; Handu, Deepa ; Isom, Kellene; Lynch, Amanda; DellaValle, Diane
In Journal of the Academy of Nutrition and Dietetics April 2019 119(4):678-686
Academic Journal
Graham LV; School of Clinical and Experimental Sciences, University of Southampton, UK.; Foxall RB; School of Cancer Sciences, University of Southampton, UK.; Antibody and Vaccine Group, Centre for Cancer Immunology, Faculty of Medicine, University of Southampton, UK.; Ashton-Key M; School of Cancer Sciences, University of Southampton, UK.; Antibody and Vaccine Group, Centre for Cancer Immunology, Faculty of Medicine, University of Southampton, UK.; Khakoo SI; School of Clinical and Experimental Sciences, University of Southampton, UK.; Sayegh S; Deparment of Ageing, Rheumatology and Regenerative Medicine, UCL, London, UK.; Department of Rheumatology, University College London Hospital, London, UK.; Leandro M; Deparment of Ageing, Rheumatology and Regenerative Medicine, UCL, London, UK.; Department of Rheumatology, University College London Hospital, London, UK.; Reddy VR; Deparment of Ageing, Rheumatology and Regenerative Medicine, UCL, London, UK.; Department of Rheumatology, University College London Hospital, London, UK.; Cragg MS; School of Cancer Sciences, University of Southampton, UK.; Antibody and Vaccine Group, Centre for Cancer Immunology, Faculty of Medicine, University of Southampton, UK.; Blunt MD; School of Clinical and Experimental Sciences, University of Southampton, UK.
Publisher: Oxford University Press Country of Publication: England NLM ID: 0057202 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1365-2249 (Electronic) Linking ISSN: 00099104 NLM ISO Abbreviation: Clin Exp Immunol Subsets: MEDLINE
Report
Fingolimod and Risk of Skin Cancer Among Individuals with Multiple Sclerosis: a Population-based Cohort Study
Jia A, Kuramoto L, Khakban A, Sio WS, Traboulsee A, De Vera MA, Oh J, Loree J, Tam R, Lynd LD,Cragg JJ. Fingolimod and risk of skin cancer among individuals with multiple sclerosis: a population-based cohort study protocol. BMJ Open. 2025 Jan 23;15(1):e088924. doi: 10.1136/bmjopen-2024-088924.
Jia A, Kuramoto L, Khakban A, Sio WS, Traboulsee A, De Vera MA, Oh J, Loree J, Tam R, Lynd LD,
Academic Journal
Elliott IG; School of Chemistry and Chemical Engineering, Faculty of Engineering and Physical Sciences, University of Southampton, Southampton, SO17 1BJ, UK.; School of Biological Sciences, Faculty of Environmental and Life Sciences, University of Southampton, Southampton, SO17 1BJ, UK.; Antibody & Vaccine Group, Centre for Cancer Immunology, School of Cancer Sciences, Faculty of Medicine, Southampton General Hospital, University of Southampton, Southampton, SO16 6YD, UK.; Institute for Life Sciences, University of Southampton, Southampton, SO17 1BJ, UK.; Fisher H; School of Chemistry and Chemical Engineering, Faculty of Engineering and Physical Sciences, University of Southampton, Southampton, SO17 1BJ, UK.; School of Biological Sciences, Faculty of Environmental and Life Sciences, University of Southampton, Southampton, SO17 1BJ, UK.; Antibody & Vaccine Group, Centre for Cancer Immunology, School of Cancer Sciences, Faculty of Medicine, Southampton General Hospital, University of Southampton, Southampton, SO16 6YD, UK.; Institute for Life Sciences, University of Southampton, Southampton, SO17 1BJ, UK.; European Synchrotron Radiation Facility, Grenoble, Cedex 9, 38043, France.; Chan HTC; Antibody & Vaccine Group, Centre for Cancer Immunology, School of Cancer Sciences, Faculty of Medicine, Southampton General Hospital, University of Southampton, Southampton, SO16 6YD, UK.; Inzhelevskaya T; Antibody & Vaccine Group, Centre for Cancer Immunology, School of Cancer Sciences, Faculty of Medicine, Southampton General Hospital, University of Southampton, Southampton, SO16 6YD, UK.; Mockridge CI; Antibody & Vaccine Group, Centre for Cancer Immunology, School of Cancer Sciences, Faculty of Medicine, Southampton General Hospital, University of Southampton, Southampton, SO16 6YD, UK.; Penfold CA; Antibody & Vaccine Group, Centre for Cancer Immunology, School of Cancer Sciences, Faculty of Medicine, Southampton General Hospital, University of Southampton, Southampton, SO16 6YD, UK.; Duriez PJ; Antibody & Vaccine Group, Centre for Cancer Immunology, School of Cancer Sciences, Faculty of Medicine, Southampton General Hospital, University of Southampton, Southampton, SO16 6YD, UK.; Orr CM; Diamond Light Source, Didcot, OX11 0FA, UK.; Herniman J; School of Chemistry and Chemical Engineering, Faculty of Engineering and Physical Sciences, University of Southampton, Southampton, SO17 1BJ, UK.; Müller KTJ; Antibody & Vaccine Group, Centre for Cancer Immunology, School of Cancer Sciences, Faculty of Medicine, Southampton General Hospital, University of Southampton, Southampton, SO16 6YD, UK.; Essex JW; School of Chemistry and Chemical Engineering, Faculty of Engineering and Physical Sciences, University of Southampton, Southampton, SO17 1BJ, UK.; Institute for Life Sciences, University of Southampton, Southampton, SO17 1BJ, UK.; Cragg MS; Antibody & Vaccine Group, Centre for Cancer Immunology, School of Cancer Sciences, Faculty of Medicine, Southampton General Hospital, University of Southampton, Southampton, SO16 6YD, UK.; Institute for Life Sciences, University of Southampton, Southampton, SO17 1BJ, UK.; Tews I; School of Biological Sciences, Faculty of Environmental and Life Sciences, University of Southampton, Southampton, SO17 1BJ, UK. Ivo.Tews@soton.ac.uk.; Institute for Life Sciences, University of Southampton, Southampton, SO17 1BJ, UK. Ivo.Tews@soton.ac.uk.
Publisher: Nature Pub. Group Country of Publication: England NLM ID: 101528555 Publication Model: Electronic Cited Medium: Internet ISSN: 2041-1723 (Electronic) Linking ISSN: 20411723 NLM ISO Abbreviation: Nat Commun Subsets: MEDLINE
Academic Journal
Widdess MA; Antibody and Vaccine Group, Centre for Cancer Immunology, School of Cancer Sciences, Faculty of Medicine, University of Southampton, Southampton, UK.; Pakidi A; Antibody and Vaccine Group, Centre for Cancer Immunology, School of Cancer Sciences, Faculty of Medicine, University of Southampton, Southampton, UK.; Metcalfe HJ; Antibody and Vaccine Group, Centre for Cancer Immunology, School of Cancer Sciences, Faculty of Medicine, University of Southampton, Southampton, UK.; Chan HTC; Antibody and Vaccine Group, Centre for Cancer Immunology, School of Cancer Sciences, Faculty of Medicine, University of Southampton, Southampton, UK.; Inzhelevskaya T; Antibody and Vaccine Group, Centre for Cancer Immunology, School of Cancer Sciences, Faculty of Medicine, University of Southampton, Southampton, UK.; Penfold CA; Antibody and Vaccine Group, Centre for Cancer Immunology, School of Cancer Sciences, Faculty of Medicine, University of Southampton, Southampton, UK.; Mockridge CI; Antibody and Vaccine Group, Centre for Cancer Immunology, School of Cancer Sciences, Faculty of Medicine, University of Southampton, Southampton, UK.; Booth SG; Antibody and Vaccine Group, Centre for Cancer Immunology, School of Cancer Sciences, Faculty of Medicine, University of Southampton, Southampton, UK.; James S; Antibody and Vaccine Group, Centre for Cancer Immunology, School of Cancer Sciences, Faculty of Medicine, University of Southampton, Southampton, UK.; Lim SH; Antibody and Vaccine Group, Centre for Cancer Immunology, School of Cancer Sciences, Faculty of Medicine, University of Southampton, Southampton, UK.; Beers SA; Antibody and Vaccine Group, Centre for Cancer Immunology, School of Cancer Sciences, Faculty of Medicine, University of Southampton, Southampton, UK.; Cragg MS; Antibody and Vaccine Group, Centre for Cancer Immunology, School of Cancer Sciences, Faculty of Medicine, University of Southampton, Southampton, UK.; Al-Shamkhani A; Antibody and Vaccine Group, Centre for Cancer Immunology, School of Cancer Sciences, Faculty of Medicine, University of Southampton, Southampton, UK. aymen@soton.ac.uk.
Publisher: Nature Pub. Group Country of Publication: England NLM ID: 101528555 Publication Model: Electronic Cited Medium: Internet ISSN: 2041-1723 (Electronic) Linking ISSN: 20411723 NLM ISO Abbreviation: Nat Commun Subsets: MEDLINE
Academic Journal
Cleary KLS; Antibody and Vaccine Group, Centre for Cancer Immunology, School of Cancer Sciences, Faculty of Medicine, University of Southampton, Southampton, United Kingdom.; Semmrich M; BioInvent International AB, Lund, Sweden.; Martensson L; BioInvent International AB, Lund, Sweden.; Tornberg UC; BioInvent International AB, Lund, Sweden.; Ermert D; BioInvent International AB, Lund, Sweden.; Taylor MC; Antibody and Vaccine Group, Centre for Cancer Immunology, School of Cancer Sciences, Faculty of Medicine, University of Southampton, Southampton, United Kingdom.; Oldham RJ; Antibody and Vaccine Group, Centre for Cancer Immunology, School of Cancer Sciences, Faculty of Medicine, University of Southampton, Southampton, United Kingdom.; Dadas O; Antibody and Vaccine Group, Centre for Cancer Immunology, School of Cancer Sciences, Faculty of Medicine, University of Southampton, Southampton, United Kingdom.; Department of Molecular Biology and Genetics, Faculty of Arts and Sciences, European University of Lefke, Mersin, Turkey.; Buckingham JF; Antibody and Vaccine Group, Centre for Cancer Immunology, School of Cancer Sciences, Faculty of Medicine, University of Southampton, Southampton, United Kingdom.; Kim J; Antibody and Vaccine Group, Centre for Cancer Immunology, School of Cancer Sciences, Faculty of Medicine, University of Southampton, Southampton, United Kingdom.; Chan HTC; Antibody and Vaccine Group, Centre for Cancer Immunology, School of Cancer Sciences, Faculty of Medicine, University of Southampton, Southampton, United Kingdom.; Palm A; BioInvent International AB, Lund, Sweden.; Fischer AH; BioInvent International AB, Lund, Sweden.; Boden M; BioInvent International AB, Lund, Sweden.; Mattsson J; BioInvent International AB, Lund, Sweden.; Holmkvist P; BioInvent International AB, Lund, Sweden.; Lim SH; Antibody and Vaccine Group, Centre for Cancer Immunology, School of Cancer Sciences, Faculty of Medicine, University of Southampton, Southampton, United Kingdom.; Beers SA; Antibody and Vaccine Group, Centre for Cancer Immunology, School of Cancer Sciences, Faculty of Medicine, University of Southampton, Southampton, United Kingdom.; Frendeus B; BioInvent International AB, Lund, Sweden.; Teige I; BioInvent International AB, Lund, Sweden.; Cragg MS; Antibody and Vaccine Group, Centre for Cancer Immunology, School of Cancer Sciences, Faculty of Medicine, University of Southampton, Southampton, United Kingdom.; University of Southampton, Institute for Life Sciences, Southampton, United Kingdom.
Publisher: American Association for Cancer Research Country of Publication: United States NLM ID: 101614637 Publication Model: Print Cited Medium: Internet ISSN: 2326-6074 (Electronic) Linking ISSN: 23266066 NLM ISO Abbreviation: Cancer Immunol Res Subsets: MEDLINE
Academic Journal
Simpson AP; Antibody and Vaccine Group, School of Cancer Sciences, Centre for Cancer Immunology, University of Southampton Faculty of Medicine, Southampton, Hampshire, UK.; Oldham RJ; Antibody and Vaccine Group, School of Cancer Sciences, Centre for Cancer Immunology, University of Southampton Faculty of Medicine, Southampton, Hampshire, UK.; Cox KL; Antibody and Vaccine Group, School of Cancer Sciences, Centre for Cancer Immunology, University of Southampton Faculty of Medicine, Southampton, Hampshire, UK.; Taylor MC; Antibody and Vaccine Group, School of Cancer Sciences, Centre for Cancer Immunology, University of Southampton Faculty of Medicine, Southampton, Hampshire, UK.; James S; Antibody and Vaccine Group, School of Cancer Sciences, Centre for Cancer Immunology, University of Southampton Faculty of Medicine, Southampton, Hampshire, UK.; White AL; Antibody and Vaccine Group, School of Cancer Sciences, Centre for Cancer Immunology, University of Southampton Faculty of Medicine, Southampton, Hampshire, UK.; Bogdanov Y; Antibody and Vaccine Group, School of Cancer Sciences, Centre for Cancer Immunology, University of Southampton Faculty of Medicine, Southampton, Hampshire, UK.; Glennie MJ; Antibody and Vaccine Group, School of Cancer Sciences, Centre for Cancer Immunology, University of Southampton Faculty of Medicine, Southampton, Hampshire, UK.; Frendeus B; Antibody and Vaccine Group, School of Cancer Sciences, Centre for Cancer Immunology, University of Southampton Faculty of Medicine, Southampton, Hampshire, UK.; BioInvent International AB, Sölvegatan 41, Lund, Sweden.; Cragg MS; Antibody and Vaccine Group, School of Cancer Sciences, Centre for Cancer Immunology, University of Southampton Faculty of Medicine, Southampton, Hampshire, UK.; Institute for Life Sciences, University of Southampton, Highfield, Southampton, UK.; Roghanian A; Antibody and Vaccine Group, School of Cancer Sciences, Centre for Cancer Immunology, University of Southampton Faculty of Medicine, Southampton, Hampshire, UK.; Institute for Life Sciences, University of Southampton, Highfield, Southampton, UK.
Publisher: Oxford University Press Country of Publication: England NLM ID: 0057202 Publication Model: Print Cited Medium: Internet ISSN: 1365-2249 (Electronic) Linking ISSN: 00099104 NLM ISO Abbreviation: Clin Exp Immunol Subsets: MEDLINE
Academic Journal
Buermann LE; Cancer Sciences Unit, University of Southampton, Southampton, United Kingdom.; Centre for Cancer Immunology, University of Southampton, Southampton, United Kingdom.; Stanton L; Cancer Research UK Southampton Clinical Trials Unit, University of Southampton, Southampton, United Kingdom.; University Hospital Southampton NHS Foundation Trust, Southampton, United Kingdom.; Rose-Zerilli MJJ; Cancer Sciences Unit, University of Southampton, Southampton, United Kingdom.; Thorne K; Cancer Research UK Southampton Clinical Trials Unit, University of Southampton, Southampton, United Kingdom.; University Hospital Southampton NHS Foundation Trust, Southampton, United Kingdom.; Coleman A; NIHR/Cancer Research UK Experimental Cancer Medicines Centre UK, Southampton, United Kingdom.; Turaj AH; Cancer Sciences Unit, University of Southampton, Southampton, United Kingdom.; Centre for Cancer Immunology, University of Southampton, Southampton, United Kingdom.; Caddy J; Cancer Research UK Southampton Clinical Trials Unit, University of Southampton, Southampton, United Kingdom.; University Hospital Southampton NHS Foundation Trust, Southampton, United Kingdom.; Wignall C; Cancer Research UK Southampton Clinical Trials Unit, University of Southampton, Southampton, United Kingdom.; University Hospital Southampton NHS Foundation Trust, Southampton, United Kingdom.; Keyworth N; Cancer Research UK Southampton Clinical Trials Unit, University of Southampton, Southampton, United Kingdom.; University Hospital Southampton NHS Foundation Trust, Southampton, United Kingdom.; Konn Z; Cancer Research UK Southampton Clinical Trials Unit, University of Southampton, Southampton, United Kingdom.; University Hospital Southampton NHS Foundation Trust, Southampton, United Kingdom.; McKay P; The Beatson West of Scotland Cancer Centre, Glasgow, United Kingdom.; Osborne W; The Newcastle Upon Tyne Hospitals NHS Foundation Trust, Newcastle, United Kingdom.; Newcastle University, Newcastle, United Kingdom.; Linton K; The Christie NHS Foundation Trust, Manchester, United Kingdom.; Medd P; Department of Haematology, Derriford Hospital, Plymouth, United Kingdom.; Lown R; University Hospital Southampton NHS Foundation Trust, Southampton, United Kingdom.; Davies AJ; Cancer Sciences Unit, University of Southampton, Southampton, United Kingdom.; Centre for Cancer Immunology, University of Southampton, Southampton, United Kingdom.; University Hospital Southampton NHS Foundation Trust, Southampton, United Kingdom.; NIHR/Cancer Research UK Experimental Cancer Medicines Centre UK, Southampton, United Kingdom.; Johnson PWM; Cancer Sciences Unit, University of Southampton, Southampton, United Kingdom.; Centre for Cancer Immunology, University of Southampton, Southampton, United Kingdom.; University Hospital Southampton NHS Foundation Trust, Southampton, United Kingdom.; Al-Shamkhani A; Cancer Sciences Unit, University of Southampton, Southampton, United Kingdom.; Centre for Cancer Immunology, University of Southampton, Southampton, United Kingdom.; Cragg MS; Cancer Sciences Unit, University of Southampton, Southampton, United Kingdom.; Centre for Cancer Immunology, University of Southampton, Southampton, United Kingdom.; Institute for Life Sciences, University of Southampton, Southampton, United Kingdom.; Collins GP; Oxford Cancer and Haematology Centre, Churchill Hospital, Oxford, United Kingdom.; Keler T; Celldex Therapeutics, Hampton, New Jersey.; Yellin M; Celldex Therapeutics, Hampton, New Jersey.; Gentles AJ; Department of Pathology, Stanford University School of Medicine, Stanford, California.; Department of Medicine (Biomedical Informatics Research), Stanford University School of Medicine, Stanford, California.; Department of Biomedical Data Science, Stanford University School of Medicine, Stanford, California.; Griffiths G; Cancer Research UK Southampton Clinical Trials Unit, University of Southampton, Southampton, United Kingdom.; University Hospital Southampton NHS Foundation Trust, Southampton, United Kingdom.; Lim SH; Cancer Sciences Unit, University of Southampton, Southampton, United Kingdom.; Centre for Cancer Immunology, University of Southampton, Southampton, United Kingdom.; University Hospital Southampton NHS Foundation Trust, Southampton, United Kingdom.; Institute for Life Sciences, University of Southampton, Southampton, United Kingdom.
Publisher: American Association for Cancer Research Country of Publication: United States NLM ID: 9502500 Publication Model: Print Cited Medium: Internet ISSN: 1557-3265 (Electronic) Linking ISSN: 10780432 NLM ISO Abbreviation: Clin Cancer Res Subsets: MEDLINE
Academic Journal
Michael Sweet; Mark Bulling; Dorsa Varshavi; Gavin R. Lloyd; Andris Jankevics; Lukáš Najdekr; Ralf J. M. Weber; Mark R. Viant; Jamie Craggs
Frontiers in Marine Science, Vol 8 (2021)
Academic Journal
Frampton S; Cancer Genomics Group, Faculty of Medicine, School of Cancer Sciences, University of Southampton, Southampton, UK.; Smith R; Antibody and Vaccine Group, Faculty of Medicine, School of Cancer Sciences, Centre for Cancer Immunology, University of Southampton, Southampton, UK.; Ferson L; Cancer Genomics Group, Faculty of Medicine, School of Cancer Sciences, University of Southampton, Southampton, UK.; Gibson J; Cancer Genomics Group, Faculty of Medicine, School of Cancer Sciences, University of Southampton, Southampton, UK.; Hollox EJ; Department of Genetics, Genomics and Cancer Sciences, College of Life Sciences, University of Leicester, Leicester, UK.; Cragg MS; Antibody and Vaccine Group, Faculty of Medicine, School of Cancer Sciences, Centre for Cancer Immunology, University of Southampton, Southampton, UK.; Strefford JC; Cancer Genomics Group, Faculty of Medicine, School of Cancer Sciences, University of Southampton, Southampton, UK.
Publisher: Blackwell Country of Publication: England NLM ID: 7702118 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1600-065X (Electronic) Linking ISSN: 01052896 NLM ISO Abbreviation: Immunol Rev Subsets: MEDLINE
Academic Journal
Graham LV; School of Clinical and Experimental Sciences, University of Southampton, Southampton, United Kingdom.; Fisher JG; School of Clinical and Experimental Sciences, University of Southampton, Southampton, United Kingdom.; Doyle ADP; School of Clinical and Experimental Sciences, University of Southampton, Southampton, United Kingdom.; Sale B; School of Cancer Sciences, University of Southampton, Southampton, United Kingdom.; Del Rio L; School of Cancer Sciences, University of Southampton, Southampton, United Kingdom.; French AJE; Anthony Nolan Research Institute, Royal Free Hospital, London, United Kingdom.; Mayor NP; Anthony Nolan Research Institute, Royal Free Hospital, London, United Kingdom.; Department of Academic Haematology, University College London (UCL) Cancer Institute, London, United Kingdom.; Turner TR; Anthony Nolan Research Institute, Royal Free Hospital, London, United Kingdom.; Department of Academic Haematology, University College London (UCL) Cancer Institute, London, United Kingdom.; Marsh SGE; Anthony Nolan Research Institute, Royal Free Hospital, London, United Kingdom.; Department of Academic Haematology, University College London (UCL) Cancer Institute, London, United Kingdom.; Cragg MS; School of Cancer Sciences, University of Southampton, Southampton, United Kingdom.; Antibody and Vaccine Group, Centre for Cancer Immunology, Faculty of Medicine, University of Southampton, Southampton, United Kingdom.; Forconi F; School of Cancer Sciences, University of Southampton, Southampton, United Kingdom.; Haematology Department, Cancer Care Directorate, University Hospital Southampton National Health Service (NHS) Trust, Southampton, United Kingdom.; Khakoo SI; School of Clinical and Experimental Sciences, University of Southampton, Southampton, United Kingdom.; Blunt MD; School of Clinical and Experimental Sciences, University of Southampton, Southampton, United Kingdom.
Publisher: Frontiers Research Foundation] Country of Publication: Switzerland NLM ID: 101568867 Publication Model: eCollection Cited Medium: Print ISSN: 2234-943X (Print) Linking ISSN: 2234943X NLM ISO Abbreviation: Front Oncol Subsets: PubMed not MEDLINE
Academic Journal
Manunga, Jesse ; Sullivan, Timothy ; Garberich, Ross ; Alden, Peter ; Alexander, Jason ; Skeik, Nedaa ; Titus, Jessica ; Stephenson, Elliott ; Cragg, Andrew
In Journal of Vascular Surgery August 2018 68(2):337-347
Academic Journal
Stockis J; CRUK Cambridge Institute, University of Cambridge, Cambridge CB2 0RE, UK.; Yip T; CRUK Cambridge Institute, University of Cambridge, Cambridge CB2 0RE, UK.; Moreno-Vicente J; CRUK Cambridge Institute, University of Cambridge, Cambridge CB2 0RE, UK.; Burton O; Immunology Programme, Babraham Institute, Cambridge CB22 3AT, UK.; Department of Pathology, University of Cambridge, Cambridge CB2 1QP, UK.; Samarakoon Y; CRUK Cambridge Institute, University of Cambridge, Cambridge CB2 0RE, UK.; Schuijs MJ; CRUK Cambridge Institute, University of Cambridge, Cambridge CB2 0RE, UK.; Raghunathan S; CRUK Cambridge Institute, University of Cambridge, Cambridge CB2 0RE, UK.; Garcia C; CRUK Cambridge Institute, University of Cambridge, Cambridge CB2 0RE, UK.; Luo W; CRUK Cambridge Institute, University of Cambridge, Cambridge CB2 0RE, UK.; Whiteside SK; Department of Pathology, University of Cambridge, Cambridge CB2 1QP, UK.; Png S; CRUK Cambridge Institute, University of Cambridge, Cambridge CB2 0RE, UK.; Simpson C; CRUK Cambridge Institute, University of Cambridge, Cambridge CB2 0RE, UK.; Monk S; CRUK Cambridge Institute, University of Cambridge, Cambridge CB2 0RE, UK.; Sawle A; CRUK Cambridge Institute, University of Cambridge, Cambridge CB2 0RE, UK.; Yin K; CRUK Cambridge Institute, University of Cambridge, Cambridge CB2 0RE, UK.; Barbieri J; CRUK Cambridge Institute, University of Cambridge, Cambridge CB2 0RE, UK.; Papadopoulos P; CRUK Cambridge Institute, University of Cambridge, Cambridge CB2 0RE, UK.; Wong H; Department of Veterinary Medicine, University of Cambridge, Cambridge CB3 0ES, UK.; Rodewald HR; Division of Cellular Immunology, German Cancer Research Center, Heidelberg 69120, Germany.; Vyse T; Department of Medical and Molecular Genetics, King's College London, London SE1 9RT, UK.; McKenzie ANJ; Medical Research Council, Laboratory of Molecular Biology, Cambridge CB2 0QH, UK.; Cragg MS; Antibody and Vaccine Group, Centre for Cancer Immunology, School of Cancer Sciences, Faculty of Medicine, University of Southampton, Southampton SO16 6YD, UK.; Hoare M; CRUK Cambridge Institute, University of Cambridge, Cambridge CB2 0RE, UK.; Department of Medicine, University of Cambridge, Cambridge CB2 0QQ, UK.; Early Cancer Institute, Hutchison Research Centre, University of Cambridge, Cambridge CB2 0XZ, UK.; Withers DR; Institute of Immunology and Immunotherapy, University of Birmingham, Birmingham B15 2TT, UK.; Fehling HJ; Institute of Immunology, University Hospital Ulm, Ulm 89081, Germany.; Roychoudhuri R; Department of Pathology, University of Cambridge, Cambridge CB2 1QP, UK.; Liston A; Immunology Programme, Babraham Institute, Cambridge CB22 3AT, UK.; Department of Pathology, University of Cambridge, Cambridge CB2 1QP, UK.; Halim TYF; CRUK Cambridge Institute, University of Cambridge, Cambridge CB2 0RE, UK.
Publisher: American Association for the Advancement of Science Country of Publication: United States NLM ID: 101688624 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2470-9468 (Electronic) Linking ISSN: 24709468 NLM ISO Abbreviation: Sci Immunol Subsets: MEDLINE
Academic Journal
Askew, K; Li, K; Olmos-Alonso, A; Garcia-Moreno, F; Liang, Y; Richardson, P; Tipton, T; Chapman, MA; Riecken, K; Beccari, S; Sierra, A; Molnár, Z; Cragg, MS; Garaschuk, O; Perry, VH; Gomez-Nicola, D
Cell Rep
Cell Reports, Vol 18, Iss 2, Pp 391-405 (2017)
Cell Reports, Vol 18, Iss 2, Pp 391-405 (2017)
Academic Journal
Graham LV; School of Clinical and Experimental Sciences, University of Southampton, Southampton, United Kingdom.; Horehajova L; School of Clinical and Experimental Sciences, University of Southampton, Southampton, United Kingdom.; Haselager MV; Department of Experimental Immunology, Amsterdam UMC, University of Amsterdam, Meibergdreef, The Netherlands.; Lymphoma and Myeloma Centre Amsterdam, LYMMCARE, Amsterdam, The Netherlands.; Cancer Centre Amsterdam, Amsterdam Institute for Infection and Immunity, Amsterdam, The Netherlands.; Amsterdam Institute for Infection and Immunity, Cancer Immunology, Amsterdam, The Netherlands.; Fisher JG; School of Clinical and Experimental Sciences, University of Southampton, Southampton, United Kingdom.; Roos JL; Department of Experimental Immunology, Amsterdam UMC, University of Amsterdam, Meibergdreef, The Netherlands.; Lymphoma and Myeloma Centre Amsterdam, LYMMCARE, Amsterdam, The Netherlands.; Cancer Centre Amsterdam, Amsterdam Institute for Infection and Immunity, Amsterdam, The Netherlands.; Amsterdam Institute for Infection and Immunity, Cancer Immunology, Amsterdam, The Netherlands.; Foxall RB; School of Cancer Sciences, University of Southampton, Southampton, United Kingdom.; Antibody and Vaccine Group, Centre for Cancer Immunology, Faculty of Medicine, University of Southampton, Southampton, United Kingdom.; John M; School of Clinical and Experimental Sciences, University of Southampton, Southampton, United Kingdom.; Cox KL; School of Cancer Sciences, University of Southampton, Southampton, United Kingdom.; Antibody and Vaccine Group, Centre for Cancer Immunology, Faculty of Medicine, University of Southampton, Southampton, United Kingdom.; Oldham RJ; School of Cancer Sciences, University of Southampton, Southampton, United Kingdom.; Antibody and Vaccine Group, Centre for Cancer Immunology, Faculty of Medicine, University of Southampton, Southampton, United Kingdom.; Taylor MC; School of Cancer Sciences, University of Southampton, Southampton, United Kingdom.; Antibody and Vaccine Group, Centre for Cancer Immunology, Faculty of Medicine, University of Southampton, Southampton, United Kingdom.; Ashton-Key M; School of Cancer Sciences, University of Southampton, Southampton, United Kingdom.; Antibody and Vaccine Group, Centre for Cancer Immunology, Faculty of Medicine, University of Southampton, Southampton, United Kingdom.; Sale B; School of Cancer Sciences, University of Southampton, Southampton, United Kingdom.; Bartlett LG; School of Clinical and Experimental Sciences, University of Southampton, Southampton, United Kingdom.; Roghanian A; School of Cancer Sciences, University of Southampton, Southampton, United Kingdom.; Antibody and Vaccine Group, Centre for Cancer Immunology, Faculty of Medicine, University of Southampton, Southampton, United Kingdom.; Eldering E; Department of Experimental Immunology, Amsterdam UMC, University of Amsterdam, Meibergdreef, The Netherlands.; Lymphoma and Myeloma Centre Amsterdam, LYMMCARE, Amsterdam, The Netherlands.; Cancer Centre Amsterdam, Amsterdam Institute for Infection and Immunity, Amsterdam, The Netherlands.; Amsterdam Institute for Infection and Immunity, Cancer Immunology, Amsterdam, The Netherlands.; Vallejo AF; School of Clinical and Experimental Sciences, University of Southampton, Southampton, United Kingdom.; Forconi F; School of Cancer Sciences, University of Southampton, Southampton, United Kingdom.; Haematology Department, Cancer Care Directorate, University Hospital Southampton NHS Trust, Southampton, United Kingdom.; Khakoo SI; School of Clinical and Experimental Sciences, University of Southampton, Southampton, United Kingdom.; Cragg MS; School of Cancer Sciences, University of Southampton, Southampton, United Kingdom.; Antibody and Vaccine Group, Centre for Cancer Immunology, Faculty of Medicine, University of Southampton, Southampton, United Kingdom.; Blunt MD; School of Clinical and Experimental Sciences, University of Southampton, Southampton, United Kingdom.
Publisher: Oxford University Press Country of Publication: England NLM ID: 101776979 Publication Model: eCollection Cited Medium: Internet ISSN: 2732-4303 (Electronic) Linking ISSN: 27324303 NLM ISO Abbreviation: Immunother Adv Subsets: PubMed not MEDLINE
Academic Journal
Carter MJ; Antibody & Vaccine Group, Centre for Cancer Immunology, School of Cancer Sciences, Faculty of Medicine, Southampton General Hospital, University of Southampton, Southampton, United Kingdom.; Bogdanov YD; Antibody & Vaccine Group, Centre for Cancer Immunology, School of Cancer Sciences, Faculty of Medicine, Southampton General Hospital, University of Southampton, Southampton, United Kingdom.; Smith RC; Antibody & Vaccine Group, Centre for Cancer Immunology, School of Cancer Sciences, Faculty of Medicine, Southampton General Hospital, University of Southampton, Southampton, United Kingdom.; Cox KL; Antibody & Vaccine Group, Centre for Cancer Immunology, School of Cancer Sciences, Faculty of Medicine, Southampton General Hospital, University of Southampton, Southampton, United Kingdom.; Frampton S; Antibody & Vaccine Group, Centre for Cancer Immunology, School of Cancer Sciences, Faculty of Medicine, Southampton General Hospital, University of Southampton, Southampton, United Kingdom.; Cancer Genomics Group, School of Cancer Sciences, Faculty of Medicine, Southampton General Hospital, University of Southampton, Southampton, United Kingdom.; Ferson L; Antibody & Vaccine Group, Centre for Cancer Immunology, School of Cancer Sciences, Faculty of Medicine, Southampton General Hospital, University of Southampton, Southampton, United Kingdom.; Cancer Genomics Group, School of Cancer Sciences, Faculty of Medicine, Southampton General Hospital, University of Southampton, Southampton, United Kingdom.; Foxall RB; Antibody & Vaccine Group, Centre for Cancer Immunology, School of Cancer Sciences, Faculty of Medicine, Southampton General Hospital, University of Southampton, Southampton, United Kingdom.; Hussain K; Antibody & Vaccine Group, Centre for Cancer Immunology, School of Cancer Sciences, Faculty of Medicine, Southampton General Hospital, University of Southampton, Southampton, United Kingdom.; Oxford Vaccine Group, Centre for Clinical Vaccinology and Tropical Medicine, Churchill Hospital, Headington, Oxford, United Kingdom.; Strefford JC; Antibody & Vaccine Group, Centre for Cancer Immunology, School of Cancer Sciences, Faculty of Medicine, Southampton General Hospital, University of Southampton, Southampton, United Kingdom.; Cancer Genomics Group, School of Cancer Sciences, Faculty of Medicine, Southampton General Hospital, University of Southampton, Southampton, United Kingdom.; Beers SA; Antibody & Vaccine Group, Centre for Cancer Immunology, School of Cancer Sciences, Faculty of Medicine, Southampton General Hospital, University of Southampton, Southampton, United Kingdom.; Institute for Life Sciences, University of Southampton, Southampton, United Kingdom.; Cragg MS; Antibody & Vaccine Group, Centre for Cancer Immunology, School of Cancer Sciences, Faculty of Medicine, Southampton General Hospital, University of Southampton, Southampton, United Kingdom.; Institute for Life Sciences, University of Southampton, Southampton, United Kingdom.
Publisher: Oxford University Press Country of Publication: England NLM ID: 2985117R Publication Model: Print Cited Medium: Internet ISSN: 1550-6606 (Electronic) Linking ISSN: 00221767 NLM ISO Abbreviation: J Immunol Subsets: MEDLINE
검색 결과 제한하기
제한된 항목
[검색어] Cragg, MS
발행연도 제한
-
학술DB(Database Provider)
저널명(출판물, Title)
출판사(Publisher)
자료유형(Source Type)
주제어
언어